Review
Open access
Aug 2026
MASLD and Cardiovascular Risk: Mechanisms and Implications for Clinical Practice
This review summarizes recent advances in epidemiology, pathophysiology, biomarkers, and treatment relevant to cardiovascular risk assessment and management of metabolic dysfunction-associated steatotic liver disease.
Sai-Nan Li, Michel Toutoungy, J. Patel et al.
· Current Hypertension Reports · 0 citations